The arrival of BrightMeds GLP-1 signifies a significant shift in how physicians approach type 2 diabetes . This new medication class provides a unique way of working that also decreases blood glucose levels but may promote a reduction in weight and boost cardiovascular outcomes. Early data suggest this approach be a a powerful option for patients d